BMY vs CRK · P/E 17, rev $24.46B vs rev $940.6M
Bristol-Myers Squibb Company (BMY) versus Comstock Resources Inc (CRK) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Comstock Resources Inc (CRK) is a oil & gas e&p company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported CRK revenue for 2026-06-30 was $940.6M. Net income was $116.2M. Revenue was up 60.1% from 2026-03-31 to 2026-06-30. CRK currently screens at market cap $6.56B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. CRK currently screens at market cap $6.56B.
Not investment advice. Open the BMY and CRK stock pages for the full models.
Not investment advice.